SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BJCT-BIOJECT-needle less injection product
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: geewiz who wrote (37)8/27/1997 4:59:00 PM
From: novice investor   of 534
 
Hi Art,

Thanks for the info on Medi-ject. With Becton Dickinson as a supporter, they should be financially secure. I had several contracts at the Immuno-Cytometry division (high tech branch) of BDX and recall quite clearly how cash rich they were. I've also had a contract at Beckman Instruments (BEC) when they were a part of SmithKline-Beecham. One thing I found most troubling at all of these medical tool companies is the extreme slowness (some doctors called them criminal negligence) of the FDA. It takes FDA such absurdly long time to do even simple tests of the tools and the tests are often inconsequential or even irrelevant. Large companies such as BDX or BEC can survive this wait for FDA approval but many small companies are often driven to bankruptcy by the ineptness of FDA. I've heard this complaints from all of the medical tool companies I've ever dealt with.

Are you going to invest in Medi-ject as well as BJCT?

NI
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News